Skip to main content
Clinical Trials/PACTR202206623958155
PACTR202206623958155
Not yet recruiting
未知

A COMPARISON OF THE EFFICACY OF 12-HOUR AND 24-HOUR MAINTENANCE REGIMEN OF MAGNESIUM SULPHATE FOR SEIZURE PROPHYLAXIS IN WOMEN WITH SEVERE PREECLAMPSIA: A TRIPLE BLIND RANDOMIZED CONTROLLED TRIA

DR ILIKANNU SAMUEL OKWUCHUKW0 sites146 target enrollmentStarted: June 22, 2022Last updated:

Overview

Phase
未知
Status
Not yet recruiting
Sponsor
DR ILIKANNU SAMUEL OKWUCHUKW
Enrollment
146

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 Year(s) to 44 Year(s) (—)
Sex
Female

Inclusion Criteria

  • 1\.Willingness and consent to participate in the study
  • 2\.All patients above 20weeks of gestation with severe preeclampsia
  • 3\.Patients without contraindication to the use of MgSO4 (e.g drug hypersensitivity, myasthenia gravis, anuria/oliguria).

Exclusion Criteria

  • 1\.Eclampsia
  • 2\.Seizure disorder patients
  • 3\.Severe preeclampsia with complications like Acute renal failure, Heart failure, HELLP syndrome, pulmonary oedema
  • 4\.Prior intake of any anticonvulsant before presentation

Investigators

Sponsor
DR ILIKANNU SAMUEL OKWUCHUKW

Similar Trials